Lt3001 Podcast Podcast Por  arte de portada

Lt3001 Podcast

Lt3001 Podcast

Escúchala gratis

Ver detalles del espectáculo

Patients with AIS and disabling symptoms often have limited treatment options, particularly when reperfusion therapies are not feasible. LT3001 (Odatroltide), a novel molecule that enhances endogenous fibrinolysis and scavenges free radicals, was evaluated in two Phase 2 trials with distinct selection strategies

Todavía no hay opiniones